A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)

Condition:   Relapsed / Refractory Mantle Cell Lymphoma (MCL) Intervention:   Drug: TQ-B3525 Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - May 24, 2020 Category: Research Source Type: clinical trials